NeuroMetBench: Patient-aware benchmarking reveals interpretation limits of transcript-derived metabolic representations in glioma

NeuroMetBench is a patient-aware benchmarking and claim-bounding framework for evaluating transcript-derived metabolic representations in glioma. This v2.0.4 reproducibility release accompanies the article “NeuroMetBench: Patient-aware benchmarking reveals interpretation limits of transcript-derived metabolic representations in glioma.”

The release contains the exact submitted manuscript and supplementary sources, patient-level derived authorities, statistical verification and multiplicity records, claim-traceability resources, cohort-accounting records, deterministic figure-generation workflows, numerical-validity checks, and a hash-locked historical computation record comprising 25 exact project artifacts.

The package supports deterministic verification of the reported derived results and explicitly preserves adverse and non-admitted findings. Raw third-party molecular matrices are not redistributed. Contemporary raw-to-final execution remains conditional on availability of external source data, historical environments and dependencies, and applicable third-party licenses.

Version 2.0.4 supersedes v2.0.3 as the synchronized post-audit publication release. The previously published v2.0.3 remains an immutable historical release.